Earnings Call Insights Recursion Pharmaceuticals outlines focused R&D pipeline with multiple catalysts through 2026 SA InsightsMon, May 05, 2025 2 Comments ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

Anthropic is calling for a global “pause” on AI development, claiming that the technology is nearing a point where it can spiral out of human control. In a lengthy blog post published Thursday, the ...

Anthropic said on Thursday frontier AI developers should establish a coordinated, verifiable way to slow down or temporarily pause development if advanced systems begin improving themselves faster ...

Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...

AI startup Anthropic has issued a warning that the fast-paced evolution of the Artificial Intelligence technology is reaching a point where it could design and develop its own successor. The startup, ...

The makers of Mythos AI warn recent models are beginning to show signs of possible escape from human control.